Improving prediction of malignancy of cytologically indeterminate thyroid nodules

被引:19
|
作者
Tysome, J. R. [1 ]
Chandra, A. [2 ]
Chang, F. [2 ]
Puwanarajah, P. [1 ]
Elliott, M. [1 ]
Caroll, P. [3 ]
Powrie, J. [3 ]
Hubbard, J. G. [4 ]
Clarke, S. E. M. [5 ]
Jeannon, J. P. [1 ]
Simo, R. [1 ]
机构
[1] Guys Hosp, Dept Otolaryngol Head & Neck Surg, Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Histopathol, London, England
[3] Guys & St Thomas NHS Fdn Trust, Dept Endocrinol, London, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Endocrine Surg, London, England
[5] Guys & St Thomas NHS Fdn Trust, Dept Nucl Med, London, England
关键词
FINE-NEEDLE-ASPIRATION; FOLLICULAR NEOPLASIA; PAPILLARY CARCINOMA; INCREASED RISK; LESIONS; OCCULT;
D O I
10.1002/bjs.6734
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Fine-needle aspiration (FNA) is essential in the investigation of thyroid nodules. The British Thyroid Association guidelines recommend clarification of whether follicular nodules are probable follicular neoplasms that require surgical excision. This study assessed the value of the subclassification of cytologically indeterminate thyroid nodules into either follicular neoplasms or other pathology. Methods: The cytology reports of all thyroid FNAs performed between November 2005 and December 2007 at a single institution reported as Thy 3 (follicular lesions) were reviewed. They were reclassified as Thy 3A (probable follicular neoplasm) or Thy 3B (probable non-neoplastic lesion), and subsequently correlated with final clinical outcome to determine the predictive value of this subclassification. Results: Forty-nine specimens were categorized as Thy 3A and 55 as Thy 3B. Of excised lesions, 14 (29 per cent) of 48 Thy 3A and 4 (10 per cent) of 42 Thy 3B nodules were malignant. If Thy 3A were to predict malignancy and Thy 3B benign disease, the sensitivity of the classification was 88 per cent, with a specificity of 55 per cent and negative predictive value of 91 per cent. Conclusion: Subclassification of Thy 3 nodules into Thy 3A and Thy 3B improves the assessment of risk for thyroid malignancy.
引用
收藏
页码:1400 / 1405
页数:6
相关论文
共 50 条
  • [31] The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules
    Hu, Theodore X.
    Nguyen, Dalena T.
    Patel, Maitraya
    Beckett, Katrina
    Douek, Michael
    Masamed, Rinat
    Rhyu, Jane
    Kim, Jiyoon
    Tseng, Chi-Hong
    Yeh, Michael W.
    Livhits, Masha J.
    THYROID, 2022, 32 (08) : 905 - 916
  • [32] Ultrasound predictors of malignancy in indeterminate thyroid nodules
    M.-L. Matthey-Gie
    S. M. Walsh
    A. C. O’Neill
    A. Lowery
    D. Evoy
    D. Gibbons
    R. S. Prichard
    S. Skehan
    E. W. McDermott
    Irish Journal of Medical Science (1971 -), 2014, 183 : 633 - 637
  • [33] Ultrasound predictors of malignancy in indeterminate thyroid nodules
    Matthey-Gie, M-L
    Walsh, S. M.
    O'Neill, A. C.
    Lowery, A.
    Evoy, D.
    Gibbons, D.
    Prichard, R. S.
    Skehan, S.
    McDermott, E. W.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 (04) : 633 - 637
  • [34] Digital Gene Expression Profiling of a Series of Cytologically Indeterminate Thyroid Nodules
    Giannini, Riccardo
    Torregrossa, Liborio
    Gottardi, Stefano
    Fregoli, Lorenzo
    Borrelli, Nicla
    Savino, Mauro
    Macerola, Elisabetta
    Vitti, Paolo
    Miccoli, Paolo
    Basolo, Fulvio
    CANCER CYTOPATHOLOGY, 2015, 123 (08) : 461 - 470
  • [35] Prognostic Significance of Singular RAS Mutations in Cytologically Indeterminate Thyroid Nodules
    Dublin, Jared C.
    Papazian, Michael
    Zan, Elcin
    Oweity, Thaira
    Sun, Wei
    Hodak, Steven
    Baldwin, Chelsey K.
    Patel, Kepal N.
    Brandler, Tamar C.
    Givi, Babak
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S172 - S173
  • [36] Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier
    Ahmadi, Sara
    Kotwal, Anupam
    Bikas, Athanasios
    Xiang, Pingping
    Goldner, Whitney
    Patel, Anery
    Hughes, Elena G.
    Longstaff, Xochitl
    Yeh, Michael W.
    Livhits, Masha J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (12): : e2231 - e2239
  • [37] Concordance of Initial and Repeat Molecular Analysis in Cytologically Indeterminate Thyroid Nodules
    Papazian, Michael
    Dublin, Jared C.
    Zan, Elcin
    Oweity, Thaira
    Baldwin, Chelsey
    Jacobson, Adam S.
    Hodak, Steven
    Patel, Kepal N.
    Brandler, Tamar C.
    Givi, Babak
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S171 - S171
  • [38] DIAGNOSTIC UTILITY OF RASMUTATION TESTING FOR REFINING CYTOLOGICALLY INDETERMINATE THYROID NODULES
    Riccio, Isabel R.
    Laforteza, Alexandra C.
    Hussein, Mohammad H.
    Linhuber, Joshua P.
    Issa, Peter P.
    Staav, Jonathan
    Fawzy, Manal S.
    Toraih, Eman A.
    Kandil, Emad
    EXCLI JOURNAL, 2024, 23 : 283 - 299
  • [39] Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules
    Teliti, Marsida
    Chytiris, Spyridon
    Coperchini, Francesca
    Cerutti, Matteo
    Grillini, Beatrice
    Gallo, Maria
    Cali, Benedetto
    Arpa, Giovanni
    Rotondi, Mario
    Magri, Flavia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [40] Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Patrick D. Chin
    Catherine Y. Zhu
    Dipti P. Sajed
    Gregory A. Fishbein
    Michael W. Yeh
    Angela M. Leung
    Masha J. Livhits
    Endocrine Pathology, 2020, 31 : 377 - 384